With questions still outnumbering answers, physicians in a long COVID clinic help patients caught in the pandemic kaleidoscope.
2-HOBA hunts down the isolevuglandins responsible for proinflammatory cytokines in rheumatoid arthritis.
Researchers find higher risks of adverse events, underutilized options for mitigation.
New studies explore advances in standard and immunosuppressive therapies.
Acting as biomarkers, microbial sRNAs indicate disease severity and drug responses.
Join our rheumatology experts as they present their latest research and innovations in clinical care.
Handheld device provides an objective approach to measuring sclerosis.
1 / 5
Drug response variability showcases opportunities for precision medicine.
Rare disease specialists work to simplify and enhance patient registry data.
A specialist on CTD-ILD says misdiagnosis and delayed treatment remain common.